Literature DB >> 3137606

Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat.

A J MacLennan1, S Atmadja, N Lee, H C Fibiger.   

Abstract

Rats received haloperidol (1.3-1.5 mg/kg/day) via their drinking water for 21 weeks. At the end of this period the density of D2 dopamine receptors and their affinity for [3H]-spiperone were measured in the striatum and medial prefrontal cortex. The chronic haloperidol treatment increased the density of D2 receptors in the striatum by 70% and in the medial prefrontal cortex by 50%. The chronic haloperidol did not significantly alter the apparent affinity of D2 receptors for [3H]-spiperone in either structure. These results indicate that the density of D2 receptors in the medial prefrontal cortex is influenced by chronic exposure to haloperidol in a manner that is very similar to the well-documented increase that occurs in the striatum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137606     DOI: 10.1007/bf00174519

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment.

Authors:  N C Bacopoulos; E G Spokes; E D Bird; R H Roth
Journal:  Science       Date:  1979-09-28       Impact factor: 47.728

2.  Dopamine receptors and schizophrenia: the neuroleptic drug problem.

Authors:  G P Reynolds; P Riederer; K Jellinger; E Gabriel
Journal:  Neuropharmacology       Date:  1981-12       Impact factor: 5.250

3.  Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.

Authors:  F Owen; A J Cross; J L Waddington; M Poulter; S J Gamble; T J Crow
Journal:  Life Sci       Date:  1980-01-07       Impact factor: 5.037

4.  Phencyclidine.

Authors:  S H Snyder
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

5.  Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis.

Authors:  T E Robinson; J B Becker; C J Moore; E Castañeda; G Mittleman
Journal:  Brain Res       Date:  1985-09-23       Impact factor: 3.252

6.  Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine.

Authors:  M B Bowers; F J Hoffman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Increased brain dopamine and dopamine receptors in schizophrenia.

Authors:  A V Mackay; L L Iversen; M Rossor; E Spokes; E Bird; A Arregui; I Creese; S H Synder
Journal:  Arch Gen Psychiatry       Date:  1982-09

8.  Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.

Authors:  E Meller; K Bohmaker; H Rosengarten; A J Friedhoff
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-09

Review 9.  Pharmacology of mesocortical dopamine neurons.

Authors:  M J Bannon; R H Roth
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

10.  Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain.

Authors:  T Matsumoto; H Uchimura; M Hirano; J S Kim; H Yokoo; M Shimomura; T Nakahara; K Inoue; K Oomagari
Journal:  Eur J Pharmacol       Date:  1983-04-22       Impact factor: 4.432

View more
  3 in total

1.  Involvement of the nucleus accumbens in stimulation of the immune response in rats after activation of opioid mu receptors with DAGO.

Authors:  L V Devoino; M A Cheido; E L Al'perina
Journal:  Neurosci Behav Physiol       Date:  2002 Sep-Oct

2.  Chronic ethanol exposure increases inhibition of optically targeted phasic dopamine release in the nucleus accumbens core and medial shell ex vivo.

Authors:  James R Melchior; Sara R Jones
Journal:  Mol Cell Neurosci       Date:  2017-09-20       Impact factor: 4.314

3.  Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.

Authors:  Y Hatta; S Hatta; T Saito
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.